Siteman Kids is the First Site of Multicenter CAR-T Trial for Autoimmune Diseases
Access to the novel immunotherapy — which “has the potential for cure” — is the latest offering by the national leader in pediatric hematology, oncology, and cell therapies. Siteman Kids at St. Louis Children’s Hospital, along with WashU Medicine in St. Louis, is the first site to test a novel immunotherapy drug for the […]
Promising Memory-Like NK Cell Therapy Spurs Trial Expansion Available Only at Siteman Kids at St. Louis Children’s Hospital and Siteman Cancer Center
ST. LOUIS — Oncologists at WashU Medicine in St. Louis are expanding an ongoing stem cell transplant study that previously enrolled only patients in remission. The study — shown to be safe and effective and aimed at preventing relapse — now also includes patients with refractory disease and those with two or more transplants. […]
More Than 30 Countries Now Participate in Siteman Kids’ Pediatric Neuro-Oncology Tumor Boards
Collaborative Approach Enhances Care for Children with Brain Tumors and NF Worldwide An international pediatric brain tumor board established by Mohamed Shebl Abdelbaki, MD, WashU Medicine pediatric oncologist and director of the Pediatric Neuro-Oncology Program at Siteman Kids at St. Louis Children’s Hospital, is rapidly becoming a collaborative, global force in efforts to better […]
New Phase 2 Clinical Trial Opens for Rare Leukemia/Lymphoma in Children
Off-the-shelf cellular therapy targets relapsed or refractory T-cell leukemia/lymphoma A potentially groundbreaking clinical trial is now open at Siteman Kids at St. Louis Children’s Hospital to evaluate an allogeneic, off-the-shelf cellular therapy designed to treat patients with relapsed or refractory T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma (T-ALL/LBL). Siteman Kids is one of […]
New Clinical Trial Focused on Relapse Prevention in Patients with Acute Myeloid Leukemia Undergoing Bone Marrow Transplant
Investigator-Initiated Trial; Only Available at Siteman Cancer Center, Siteman Kids in St. Louis ST. LOUIS — A new and promising clinical trial aimed at preventing relapse in patients diagnosed with acute myeloid leukemia (AML) is now open at Washington University School of Medicine in St. Louis. The trial (NCT06158828) is only available to […]